HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences

December 21, 2023

https://www.globenewswire.com/news-release/2023/12/21/2799897/0/en/HOOKIPA-Pharma-Announces-21-25-Million-Equity-Investment-from-Gilead-Sciences.html

NEW YORK and VIENNA, Austria, Dec. 21, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that Gilead Sciences (‘Gilead’) has purchased 15 million shares of HOOKIPA’s common stock for approximately $21.25 million, at a price of $1.4167 per share.

Read more at globenewswire.com

Related news for (HOOK)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.